Effects of hypoxia reoxygenation in brain slices from rats with type 1-like diabetes mellitus

Diabetes/Metabolism Research and Reviews

Volumn 22, Issue 5, 2006, Pages 390-400

  Gonzalez Correa J A ^a   Arrebola, M M ^a   Cansino, A L ^a   Munoz Marin J ^a   Ruiz Villafranca, D ^a   Guerrero, A ^a   Sanchez de la Cuesta F ^a   De La Cruz, J P ^a  

^a UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

Brain hyproxia; Diabetes; Nitric oxide; Oxidative stress

Indexed keywords

GLUTATHIONE; INDUCIBLE NITRIC OXIDE SYNTHASE; LACTATE DEHYDROGENASE; LIPID PEROXIDE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; PROSTAGLANDIN E2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HYPOXIA; BRAIN SLICE; CONTROLLED STUDY; DISEASE DURATION; DISEASE PREDISPOSITION; ENZYME ACTIVITY; IN VITRO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; LIPID PEROXIDATION; MALE; NERVE CELL NECROSIS; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; REOXYGENATION;

ANIMALS; ANOXIA; BRAIN; DIABETES MELLITUS, EXPERIMENTAL; L-LACTATE DEHYDROGENASE; NITRATES; NITRITES; OXYGEN CONSUMPTION; RATS; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 33749003466     PISSN: 15207552     EISSN: 15207560     Source Type: Journal    
DOI: 10.1002/dmrr.650     Document Type: Article

References (41)

1. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813-820.
2. Nishikawa T, Edelstein D, Brownlee M. The missing link: a single unifying mechanism for diabetic complications. Kidney Int 2000; 58: 26-30.
3. Rosen P, Nawroth PP, King G, Moller W, Trischler HJ, Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association, and the German Diabetes Society. Diabetes Metab Res Rev 2001; 17: 189-212.
4. Aydin A, Orhan H, Sayal A, Özata M, Sahin G, Isimer A. Oxidative stress and nitric oxide related parameters in type II diabetes mellitus: effects of glycemia control. Clin Biochem 2001; 34: 65-70.
5. Giugliano D, Ceriello A, Paolisso G. Oxidative stress and diabetic vascular complications. Diabetes Care 1996; 19: 257-267.
6. Kontos HA. Oxygen radicals in cerebral ischemia: the 2001 Willis Lecture. Stroke 2001; 32: 2712-2716.
7. Chakrabarti S, Cukiernik M, Hileeto D, Evans T, Chen S. Role of vasoactive factors in the pathogenesis of early changes in diabetic retinopathy. Diabetes Metab Res Rev 2000; 16: 393-407.
8. Bell DS. Stroke in the diabetic patients. Diabetes Care 1994; 17: 213-219.
9. Laing SP, Swerdlow AJ, Carpenter LM, et al. Mortality from cerebrovascular disease in a cohort of 23 000 patients with insulin-treated diabetes. Stroke 2003; 34: 418-421.
10. Bardell AL, MacLeod KM. Evidence for inducible nitric-oxide synthase expression and activity in vascular smooth muscle of streptozotocin-diabetic rats. J Pharmacol Exp Ther 2001; 296: 252-259.
11. De La Cruz JP, Moreno A, Guerrero A, Sánchez de la Cuesta F. Antiplatelet effects of prostacyclin and nitric oxide in patients with type I diabetes and ischemic or edematous retinopathy. Platelets 2001; 12: 210-217.
12. Boeri D, Maiello M, Lorenzi M. Increased prevalence of microthromboses in retinal capillaries of diabetic individuals. Diabetes 2001; 50: 1432-1439.
13. De Vriese AS, Verbeuren TJ, van de Voorde J, Lameire NH, Vanhoutte PM. Endothelial dysfunction in diabetes. Br J Pharmacol 2000; 130: 963-974.
14. De La Cruz JP, Villalobos MA, Sedeño G, Sánchez de la Cuesta F. Effect of propofol on oxidative stress in an in vitro model of hypoxia-reoxygenation in the rat brain. Brain Res 1998; 800: 136-144.
15. De La Cruz JP, Carrasco T, Ortega G, Sánchez De La Cuesta F. Inhibition of ferrous-induced lipid peroxidation by pyrimido-pyrimidine derivatives in human liver membranes. Lipids 1992; 27: 192-194.
16. Bossman HB, Hemsworth BD. Structure and Function of Nervous System. Academic Press: London, 1969; 1-24.
17. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248-254.
18. Hissin PJ, Hill R. A fluorimetric method of determination of oxidized and reduced glutathione in tissues. Anal Biochem 1976; 74: 214-226.
19. Flohé L, Gunzler WA. Assays of glutathione peroxidase. Methods Enzymol 1985; 105: 114-121.
20. Warholm M, Guthenberg C, von Bahr C, Mannervik B. Glutathione transferases from human liver. Methods Enzymol 1985; 113: 449-503.
21. Lobner D. Comparison of the LDH and MTT assays for quantifying cell death: validity for neuronal apoptosis?. J Neurosci Methods 2000; 96: 147-152.
22. De La Cruz JP, Guerrero A, González-Correa JA, Arrebola MM, Sánchez De La Cuesta F. Antioxidant effect of acetylsalicylic acid in rat brain slices subjected to hypoxia. J Neurosci Res 2004; 75: 280-290.
23. González-Correa JA, Arrebola MM, Ureña I, et al. Effects of triflusal in rat brain oxidative stress, prostaglandin production and nitric oxide pathway in a model of reoxygenation after oxygen-glucose deprivation. Brain Res 2004; 1011: 148-155.
24. Reagan LP, Magarinos AM, Yee DK, et al. Oxidative stress and HNE conjugation of GLUT 3 are increased in the hippocampus of diabetic rats subjected to stress. Brain Res 2000; 862: 292-300.
25. Sun F, Iwaguchi K, Shudo R, et al. Change in tissue concentrations of lipid hydroperoxydes, vitamin C and vitamin E in rats with streptozotocin-induced diabetes. Clin Sci 1999; 96: 185-190.
26. Vessby J, Basu S, Mohsen R, Berne C, Vessby B. Oxidative stress and antioxidant status in type I diabetes mellitus. J Intern Med 2002; 251: 69-76.
27. Genet S, Kale RK, Baquer NZ. Alterations in antioxidant enzymes and oxidative damage in experimental diabetic rat tissues: effect of Vanadate and Fenugreek (Trigonella Foenum Graecum). Mol Cell Biochem 2002; 236: 7-12.
28. Ramanathan M, Jaiswal AK, Bhattacharya SK. Superoxide dismutase, catalase and glutation peroxidase activities in the brain of streptozotocin induced diabetic rats. Ind J Exp Biol 1999; 37: 182-183.
29. De La Cruz JP, Guerrero A, Paniego MJ, Arranz I, Moreno A, Sánchez de la Cuesta F. Effect of aspirin on prostanoids and nitric oxide production in streptozotocin-diabetic rats with ischemic retinopathy. Naunyn Schmiedebergs Arch Pharmacol 2002; 365: 96-101.
30. Moreno A, De la Cruz JP, García Campos J, Sánchez de la Cuesta F. Prostacyclin/thromboxane balance and retinal vascular pattern in diabetic rats. Can J Ophthalmol 1995; 30: 117-123.
31. Hishinuma T, Tsukamoto H, Suzuki K, Mizugaki M. Relationship between thromboxane/prostacyclin ratio and diabetic vascular complications. Prostaglandins Leukot Essent Fatty Acids 2001; 65: 191-196.
32. Cosenzi A, Bernobich E, Bonavita M, Trevisan R, Bellini G, Campanacci L. Early effects of diabetes on inducible nitric oxide synthase in the kidney. Acta Diabetol 2002; 39: 91-96.
33. Ellis AE, Guberski DL, Huston B, Grant MB. Time course of NADH oxidase, inducible nitric oxide synthase and peroxynitrite in diabetic retinopathy in the BBZ/WOR rat. Nitric Oxide 2002; 6: 295-304.
34. Tekkök S, Kriz J, Padjen AL, Krnjevi'c K. Higher sensitivity of CA1 synapses to aglycemia in streptozotocin-diabetic rats is age-dependent. Brain Res 1998; 813: 268-273.
35. Li C, Li PA, He Q, Ouyang YB, Siesjö BK. Effects of streptozotocin-induced hyperglycemia on brain damage following transient ischemia. Neurobiol Dis 1998; 5: 117-128.
36. Muranyi M, Fujika M, He Q. Diabetes activates cell death pathway after transient focal cerebral ischemia. Diabetes 2003; 52: 481-486.
37. Wang GX, Li GR, Wang YD, Yangs TS, Ouyang YB. Characterization of neuronal cell death in normal and diabetic rats following experimental focal cerebral ischemia. Life Sci 2001; 69: 2801-2810.
38. Moro MA, De Alba J, Cárdenas A, et al. Mechanisms of the neuroprotective effect of aspirin after oxygen and glucose deprivation in rat forebrain slices. Neuropharmacology 2000; 39: 1309-1318.
39. Santos MS, Santos DL, Palmeira CM, Seiga RA, Moreno AS, Oliveira CR. Brain and liver mitochondria isolated from diabetic goto-kakizaki rats show different susceptibility to induce oxidative stress. Diabetes Metab Res Rev 2001; 17: 223-230.
40. Jeremy JH, Mikhalidis DP, Thompson CS, Dandona P. Changes in eicosanoid synthesis in the cerebrum, cerebellum and brain stem of the diabetic rat. Diabetes Res 1987; 6: 95-98.
41. Cardenas A, De Alba J, Moro MA, Leza JC, Lorenzo P, Lizasoain I. Protective effect of N-(3-(aminomethyl)benzyl) acetamidine, an inducible nitric oxide synthase inhibitor, in brain slices exposed to oxygen-glucose deprivation. Eur J Pharmacol 1998; 354: 161-165.